1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran, z.sharifi@ibto.ir
*Corresponding Author: Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran. Tel: +98-2188601501-30, Fax: +98-2188601555, E-mail: z.sharifi@ibto.ir, z.sharifi@ibto.ir. Email: z.sharifi@ibto.ir
Hepatitis C virus (HCV) is the main cause of infection that has the potential to cause chronic liver disease. Injecting drug users (IDUs) have a key role in HCV transmission in Iran. Knowledge of the distribution of various genotypes is essential for successful future research and control strategies.
Objectives:
The aim of this study was to identify HCV genotypes among chronic infected injecting drug users (IDUs) in Tehran, Iran.
Patients and Methods:
In this cross sectional study, we investigated HCV genotypes among 36 plasma samples from HCV infected IDUs (35 male and 1female, mean age: 33.67, and age range 20-62 years), referred to Research Center of Iranian Blood Transfusion Organization(IBTO) in Tehran from December 2008 to March 2009.HCV Genotyping was performed using type-specific primers.
Results:
Genotypes 3a, 1a and 1b were found in 58.3 %, 25% and 16.7 % patients, respectively.
Conclusions:
Our study demonstrated the high prevalence of genotype 3a among injecting drug users, which is also found in Europe and United states.
How to Cite:Ranjbar Kermani F, Sharifi Z, Ferdowsian F, Paz Z, Zamanian M. Distribution of Hepatitis C Virus Genotypes Among Chronic Infected Injecting Drug Users in Tehran, Iran. Jundishapur J Microbiol. 2013;6(3):. doi: https://doi.org/10.5812/jjm.5191
Sharhani A, Mehrabi Y, Noroozi A, Nasirian M, Higgs P, et al. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran. Hepat Mon. 2017;17(10):e58739. doi: https://doi.org/10.5812/hepatmon.58739
Amin-Esmaeili M, Amin-Esmaeili M, Rahimi-Movaghar A, Rahimi-Movaghar A, Razaghi E, et al. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon. 2011;12(1):. doi: https://doi.org/10.5812/kowsar.1735143X.806
Hedayati-Moghaddam MR, Danaee M, Soltanian H, Vahedi SA, Mosavat A, et al. Epidemiology of Hepatitis C Virus Infection Among High-risk Populations in Northeastern Iran. Hepat Mon. 2022;22(1):e127166. doi: https://doi.org/10.5812/hepatmon-127166
Ranjbar Kermani F, Mousavi Hosseini K, Amini-Kafiabad S, Maghsudlu M, Sharifi Z, et al. Phylogenetic Analysis of NS5B Region of Hepatitis C Genotype 3a Virus among Different Risk Groups in Iran. Hepat Mon. 2020;20(12):e108936. doi: https://doi.org/10.5812/hepatmon.108936
Norouzian H, Gholami M, Shakib P, Goudarzi G, Ghobadian Diali H, et al. Prevalence of HCV Infections and Co-Infection With HBV and HIV and Associated Risk Factors Among Addicts in Drug Treatment Centers, Lorestan Province, Iran. Int J High Risk Behav Addict. 2016;5(1):e25028. doi: https://doi.org/10.5812/ijhrba.25028